Are you from this Company?
F. HOFFMANN-LA ROCHE AG
Likes
68 Buyers Negotiating
Strengths
  • +5
    Asia-Pacific
  • +14
    Europe
  • +6
    RoW
  • +7
    Directly
  • +11
    Data analysis/genetic testing
  • +10
    Ion Semiconductor Sequencing
  • +11
    Nanopore Sequencing
  • +13
    Next Seq/Miseq/MiniSeq
  • +6
    Bioinformatics and Data analysis services
  • +13
    Chromatin immunoprecipitation sequencing (Chip-Seq)
  • +8
    Custom Gene Panel
  • +12
    Exome Sequencing
  • +7
    Others (amplicon sequencing, epigenomics, metagenomics, antibody sequencing, digital karyotyping, Digital gene expression)
  • +10
    RNA-Seq
  • +12
    Roche platform/10x chromium
  • +9
    Targeted Re-sequencing
  • +14
    Whole Genome Sequencing
  • +6
    Pacbio sequencer
  • +14
    Hospitals & Clinics
  • +6
    Other End Users (Non-profit Organizations, Agrigenomics Organizations, and Consumer Genomics Companies)
Cautions
  • -12
    Delivery
  • -8
    Nanopore sequencer/chromium
  • -11
    Breadth and Depth of Product Offering
  • -14
    Market Presence + Global
  • -13
    North America
  • -10
    DNA/RNA sequencing
  • -9
    Sample preparation
  • -9
    Single-molecule Real-time (SMRT) Sequencing
  • -13
    Research Centers and Academic & Government Institutes
  • -8
    Through Partners / Third-Party Vendors
  • -14
    H series
  • -12
    Own Platform
  • -5
    Bisulfite Sequencing (Methyl-Seq)
  • -11
    De novo Sequencing
  • -5
    Iontorrent 1
  • -5
    Pharmaceutical & Biotechnology Companies
  • -13
    Focus on Product Innovation
  • -7
    Roche/454 GS FLX
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup